"UPMC Hillman Cancer Center at Butler Health System (Medical Oncology) is a cancer treatment center located in Butler.Visit our website to learn more about the conditions we treat and the services we offer. Schedule your appointment today. UPMC is committed to protecting our communities from the spread of COVID-19. We continue to require people who come to any UPMC facility to wear a facemask that covers their nose and mouth and to practice other preventative efforts like social distancing, even if fully vaccinated."

During the past decade, UPMC Hillman Cancer Center at Butler Health System conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Hillman Cancer Center at Butler Health System" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "UPMC Hillman Cancer Center at Butler Health System" are "ALK Gene Rearrangement" (1 trials), "ALK Gene Translocation" (1 trials), "ALK Positive" (1 trials), "Advanced Lung Non-Small Cell Carcinoma" (1 trials) and "Advanced Malignant Solid Neoplasm" (1 trials). Many other conditions were trialed in "UPMC Hillman Cancer Center at Butler Health System" in a lesser frequency.

Most popular intervention types in "UPMC Hillman Cancer Center at Butler Health System" are "Drug" (10 trials), "Biological" (7 trials), "Procedure" (7 trials), "Other" (5 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Computed Tomography" (6 trials), "Magnetic Resonance Imaging" (4 trials), "Paclitaxel" (4 trials), "Biospecimen Collection" (3 trials) and "Carboplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "UPMC Hillman Cancer Center at Butler Health System" are 9 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "UPMC Hillman Cancer Center at Butler Health System". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in UPMC Hillman Cancer Center at Butler Health System, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UPMC Hillman Cancer Center at Butler Health System, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".